|
시장보고서
상품코드
1886339
자폐 스펙트럼 장애 치료 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 유형별, 용도별, 유통 채널별, 지역별 및 경쟁별 세분화(2020-2030년)Autism Spectrum Disorders Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Distribution Channel, By Region and Competition, 2020-2030F |
||||||
세계의 자폐 스펙트럼 장애 치료 시장은 2024년에 17억 1,000만 달러로 평가되며, 2030년까지 CAGR 5.39%로 성장하며, 23억 4,000만 달러에 달할 것으로 예측되고 있습니다. 세계 자폐 스펙트럼 장애(ASD) 치료 시장은 사회적 상호작용, 의사소통, 반복적 행동의 문제로 특징지어지는 복잡한 신경발달장애를 해결하기 위해 고안된 다양한 치료적 개입 및 지원 서비스를 포함하고 있습니다.
| 시장 개요 | |
|---|---|
| 예측 기간 | 2026-2030년 |
| 시장 규모 : 2024년 | 17억 1,000만 달러 |
| 시장 규모 : 2030년 | 23억 4,000만 달러 |
| CAGR : 2025-2030년 | 5.39% |
| 가장 빠르게 성장하는 부문 | 항정신병약 |
| 최대 시장 | 북미 |
주요 시장 성장 촉진요인
자폐 스펙트럼 장애의 유병률 증가는 세계 자폐 스펙트럼 장애 치료제 시장의 주요 촉진요인으로, 전문적인 치료가 필요한 환자 수가 크게 증가하고 있습니다. 이러한 증가 추세는 행동치료와 교육치료에서 약물 치료에 이르기까지 다양한 치료적 개입에 대한 지속적인 수요를 창출하고 있습니다.
주요 시장 과제
세계 자폐 스펙트럼 장애 치료제 시장을 가로막는 가장 큰 문제는 전문가 부족과 적절한 인프라 부족입니다. 이러한 부족은 특히 전 세계 의료 서비스가 부족한 지역에서 영향을 받는 인구의 상당 부분이 필요한 치료적 개입에 대한 접근을 직접적으로 제한하고 있습니다.
주요 시장 동향
인공지능(AI) 및 기술 기반 치료 솔루션의 발전은 자폐 스펙트럼 장애 치료의 개발 및 제공을 변화시키는 중요한 추세입니다. 이러한 혁신은 개인화된 개입의 가능성을 창출하고, 커뮤니케이션 지원 툴을 개선하며, 진단의 정확도를 높이고 있습니다.
자주 묻는 질문
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 자폐 스펙트럼 장애 치료 시장 전망
- 시장 규모·예측
- 금액별
- 시장 점유율·예측
- 유형별(항정신병약, 선택적 세로토닌 재흡수 저해제, 흥분제, 수면제, 기타)
- 적응증별(자폐 스펙트럼 장애, 아스퍼거 증후군, 전반적 발달 장애, 기타)
- 유통 채널별(병원 약국, 소매 약국, 온라인 약국)
- 지역별
- 기업별(2024)
- 시장 맵
제6장 북미의 자폐 스펙트럼 장애 치료 시장 전망
- 시장 규모·예측
- 시장 점유율·예측
- 북미 : 국가별 분석
- 미국
- 캐나다
- 멕시코
제7장 유럽의 자폐 스펙트럼 장애 치료 시장 전망
- 시장 규모·예측
- 시장 점유율·예측
- 유럽 : 국가별 분석
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
제8장 아시아태평양의 자폐 스펙트럼 장애 치료 시장 전망
- 시장 규모·예측
- 시장 점유율·예측
- 아시아태평양 : 국가별 분석
- 중국
- 인도
- 일본
- 한국
- 호주
제9장 중동 및 아프리카의 자폐 스펙트럼 장애 치료 시장 전망
- 시장 규모·예측
- 시장 점유율·예측
- 중동 및 아프리카 : 국가별 분석
- 사우디아라비아
- 아랍에미리트
- 남아프리카공화국
제10장 남미의 자폐 스펙트럼 장애 치료 시장 전망
- 시장 규모·예측
- 시장 점유율·예측
- 남미 : 국가별 분석
- 브라질
- 콜롬비아
- 아르헨티나
제11장 시장 역학
- 촉진요인
- 과제
제12장 시장 동향과 발전
- 합병·인수
- 제품 출시
- 최근 동향
제13장 세계의 자폐 스펙트럼 장애 치료 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
- 업계내 경쟁
- 신규 참여의 가능성
- 공급업체의 힘
- 고객의 힘
- 대체품의 위협
제15장 경쟁 구도
- Curemark LLC
- Bristol-Myers Squibb Company
- Merck KGaA
- Novartis AG
- Eli Lilly and Company
- Pfizer Inc.
- Johnson & Johnson Services, Inc.
- Otsuka Pharmaceutical Co., Ltd.
- Yamo Pharmaceuticals LLC
- F. Hoffmann-La Roche Ltd.
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA 25.12.19The Global Autism Spectrum Disorders Treatment Market, valued at USD 1.71 Billion in 2024, is projected to experience a CAGR of 5.39% to reach USD 2.34 Billion by 2030. The Global Autism Spectrum Disorders (ASD) Treatment Market encompasses a range of therapeutic interventions and support services designed to address the complex neurodevelopmental conditions characterized by challenges in social interaction, communication, and repetitive behaviors.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 1.71 Billion |
| Market Size 2030 | USD 2.34 Billion |
| CAGR 2025-2030 | 5.39% |
| Fastest Growing Segment | Antipsychotic drugs |
| Largest Market | North America |
Key Market Drivers
The increasing prevalence of Autism Spectrum Disorders is a primary driver for the Global Autism Spectrum Disorders Treatment Market, significantly expanding the patient population in need of specialized care. This rising incidence creates a sustained and growing demand for a broad spectrum of therapeutic interventions, ranging from behavioral and educational therapies to pharmacological management.
Key Market Challenges
A significant challenge hindering the Global Autism Spectrum Disorders Treatment Market is the limited availability of specialized professionals and adequate infrastructure. This scarcity directly restricts access to essential therapeutic interventions for a substantial portion of the affected population, particularly within underserved regions globally. Consequently, potential market growth remains unrealized as a considerable demand for treatment goes unmet due to the inability to deliver services effectively.
Key Market Trends
Advancements in AI and technology-based therapeutic solutions represent a significant trend, transforming the development and delivery of autism spectrum disorder treatments. These innovations are creating new possibilities for personalized interventions, improving communication aids, and enhancing diagnostic precision.
Key Market Players
- Curemark LLC
- Bristol-Myers Squibb Company
- Merck KGaA
- Novartis AG
- Eli Lilly and Company
- Pfizer Inc.
- Johnson & Johnson Services, Inc.
- Otsuka Pharmaceutical Co., Ltd.
- Yamo Pharmaceuticals LLC
- F. Hoffmann-La Roche Ltd.
Report Scope:
In this report, the Global Autism Spectrum Disorders Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Autism Spectrum Disorders Treatment Market, By Type:
- Antipsychotic Drugs
- Selective Serotonin Reuptake Inhibitors
- Stimulants
- Sleep Medication
- Others
Autism Spectrum Disorders Treatment Market, By Application:
- Autistic Disorder
- Asperger Syndrome
- Pervasive Development Disorder
- Others
Autism Spectrum Disorders Treatment Market, By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Autism Spectrum Disorders Treatment Market, By Region:
- North America
- Europe
- Asia-Pacific
- South America
- MEA
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Autism Spectrum Disorders Treatment Market.
Available Customizations:
Global Autism Spectrum Disorders Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Autism Spectrum Disorders Treatment Market Outlook
- 5.1. Market Size & Forecast
- 5.1.1. By Value
- 5.2. Market Share & Forecast
- 5.2.1. By Type (Antipsychotic Drugs, Selective Serotonin Reuptake Inhibitors, Stimulants, Sleep Medication, Others)
- 5.2.2. By Application (Autistic Disorder, Asperger Syndrome, Pervasive Development Disorder, Others)
- 5.2.3. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
- 5.3. Market Map
6. North America Autism Spectrum Disorders Treatment Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Application
- 6.2.3. By Distribution Channel
- 6.2.4. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Autism Spectrum Disorders Treatment Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.1.1. By Value
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Type
- 6.3.1.2.2. By Application
- 6.3.1.2.3. By Distribution Channel
- 6.3.1.1. Market Size & Forecast
- 6.3.2. Canada Autism Spectrum Disorders Treatment Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.1.1. By Value
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Type
- 6.3.2.2.2. By Application
- 6.3.2.2.3. By Distribution Channel
- 6.3.2.1. Market Size & Forecast
- 6.3.3. Mexico Autism Spectrum Disorders Treatment Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.1.1. By Value
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Type
- 6.3.3.2.2. By Application
- 6.3.3.2.3. By Distribution Channel
- 6.3.3.1. Market Size & Forecast
- 6.3.1. United States Autism Spectrum Disorders Treatment Market Outlook
7. Europe Autism Spectrum Disorders Treatment Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Application
- 7.2.3. By Distribution Channel
- 7.2.4. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. Germany Autism Spectrum Disorders Treatment Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Type
- 7.3.1.2.2. By Application
- 7.3.1.2.3. By Distribution Channel
- 7.3.1.1. Market Size & Forecast
- 7.3.2. France Autism Spectrum Disorders Treatment Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Type
- 7.3.2.2.2. By Application
- 7.3.2.2.3. By Distribution Channel
- 7.3.2.1. Market Size & Forecast
- 7.3.3. United Kingdom Autism Spectrum Disorders Treatment Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Type
- 7.3.3.2.2. By Application
- 7.3.3.2.3. By Distribution Channel
- 7.3.3.1. Market Size & Forecast
- 7.3.4. Italy Autism Spectrum Disorders Treatment Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.1.1. By Value
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Type
- 7.3.4.2.2. By Application
- 7.3.4.2.3. By Distribution Channel
- 7.3.4.1. Market Size & Forecast
- 7.3.5. Spain Autism Spectrum Disorders Treatment Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.1.1. By Value
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Type
- 7.3.5.2.2. By Application
- 7.3.5.2.3. By Distribution Channel
- 7.3.5.1. Market Size & Forecast
- 7.3.1. Germany Autism Spectrum Disorders Treatment Market Outlook
8. Asia Pacific Autism Spectrum Disorders Treatment Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Application
- 8.2.3. By Distribution Channel
- 8.2.4. By Country
- 8.3. Asia Pacific: Country Analysis
- 8.3.1. China Autism Spectrum Disorders Treatment Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Type
- 8.3.1.2.2. By Application
- 8.3.1.2.3. By Distribution Channel
- 8.3.1.1. Market Size & Forecast
- 8.3.2. India Autism Spectrum Disorders Treatment Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Type
- 8.3.2.2.2. By Application
- 8.3.2.2.3. By Distribution Channel
- 8.3.2.1. Market Size & Forecast
- 8.3.3. Japan Autism Spectrum Disorders Treatment Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Type
- 8.3.3.2.2. By Application
- 8.3.3.2.3. By Distribution Channel
- 8.3.3.1. Market Size & Forecast
- 8.3.4. South Korea Autism Spectrum Disorders Treatment Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Type
- 8.3.4.2.2. By Application
- 8.3.4.2.3. By Distribution Channel
- 8.3.4.1. Market Size & Forecast
- 8.3.5. Australia Autism Spectrum Disorders Treatment Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Type
- 8.3.5.2.2. By Application
- 8.3.5.2.3. By Distribution Channel
- 8.3.5.1. Market Size & Forecast
- 8.3.1. China Autism Spectrum Disorders Treatment Market Outlook
9. Middle East & Africa Autism Spectrum Disorders Treatment Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Application
- 9.2.3. By Distribution Channel
- 9.2.4. By Country
- 9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Autism Spectrum Disorders Treatment Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Type
- 9.3.1.2.2. By Application
- 9.3.1.2.3. By Distribution Channel
- 9.3.1.1. Market Size & Forecast
- 9.3.2. UAE Autism Spectrum Disorders Treatment Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Type
- 9.3.2.2.2. By Application
- 9.3.2.2.3. By Distribution Channel
- 9.3.2.1. Market Size & Forecast
- 9.3.3. South Africa Autism Spectrum Disorders Treatment Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Type
- 9.3.3.2.2. By Application
- 9.3.3.2.3. By Distribution Channel
- 9.3.3.1. Market Size & Forecast
- 9.3.1. Saudi Arabia Autism Spectrum Disorders Treatment Market Outlook
10. South America Autism Spectrum Disorders Treatment Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Application
- 10.2.3. By Distribution Channel
- 10.2.4. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Autism Spectrum Disorders Treatment Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Type
- 10.3.1.2.2. By Application
- 10.3.1.2.3. By Distribution Channel
- 10.3.1.1. Market Size & Forecast
- 10.3.2. Colombia Autism Spectrum Disorders Treatment Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Type
- 10.3.2.2.2. By Application
- 10.3.2.2.3. By Distribution Channel
- 10.3.2.1. Market Size & Forecast
- 10.3.3. Argentina Autism Spectrum Disorders Treatment Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Type
- 10.3.3.2.2. By Application
- 10.3.3.2.3. By Distribution Channel
- 10.3.3.1. Market Size & Forecast
- 10.3.1. Brazil Autism Spectrum Disorders Treatment Market Outlook
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Merger & Acquisition (If Any)
- 12.2. Product Launches (If Any)
- 12.3. Recent Developments
13. Global Autism Spectrum Disorders Treatment Market: SWOT Analysis
14. Porter's Five Forces Analysis
- 14.1. Competition in the Industry
- 14.2. Potential of New Entrants
- 14.3. Power of Suppliers
- 14.4. Power of Customers
- 14.5. Threat of Substitute Products
15. Competitive Landscape
- 15.1. Curemark LLC
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
- 15.2. Bristol-Myers Squibb Company
- 15.3. Merck KGaA
- 15.4. Novartis AG
- 15.5. Eli Lilly and Company
- 15.6. Pfizer Inc.
- 15.7. Johnson & Johnson Services, Inc.
- 15.8. Otsuka Pharmaceutical Co., Ltd.
- 15.9. Yamo Pharmaceuticals LLC
- 15.10. F. Hoffmann-La Roche Ltd.
